BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1029 related articles for article (PubMed ID: 31173403)

  • 1. LncRNA TTN-AS1 drives invasion and migration of lung adenocarcinoma cells via modulation of miR-4677-3p/ZEB1 axis.
    Zhong Y; Wang J; Lv W; Xu J; Mei S; Shan A
    J Cell Biochem; 2019 Oct; 120(10):17131-17141. PubMed ID: 31173403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
    Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
    J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5.
    Jia Y; Duan Y; Liu T; Wang X; Lv W; Wang M; Wang J; Liu L
    Cell Death Dis; 2019 Jul; 10(8):573. PubMed ID: 31363080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZEB1-AS1 mediates bone metastasis through targeting miR-320b/BMPR1A axis in lung cancer.
    Tan N; Tang J; Chen G; Jiang W; Liu Z
    Clin Respir J; 2024 May; 18(5):e13770. PubMed ID: 38783645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA ZEB1-AS1/miR-409-3p/ZEB1 feedback loop is involved in the progression of non-small cell lung cancer.
    Qu R; Chen X; Zhang C
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):450-456. PubMed ID: 30448056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

  • 7. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.
    Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y
    Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA TTN-AS1 sponges miR-376a-3p to promote colorectal cancer progression via upregulating KLF15.
    Wang Y; Jiang F; Xiong Y; Cheng X; Qiu Z; Song R
    Life Sci; 2020 Mar; 244():116936. PubMed ID: 31610194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long noncoding RNA LINC00483 promotes lung adenocarcinoma progression by sponging miR-204-3p.
    Yang S; Liu T; Sun Y; Liang X
    Cell Mol Biol Lett; 2019; 24():70. PubMed ID: 31889958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TTN-AS1 delivered by gastric cancer cell-derived exosome induces gastric cancer progression through in vivo and in vitro studies.
    Wang Y; Jiang R; Zhao H; Li F; Li Y; Zhu M
    Cell Biol Toxicol; 2023 Apr; 39(2):557-571. PubMed ID: 36214926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA ZEB1-AS1 promotes pulmonary fibrosis through ZEB1-mediated epithelial-mesenchymal transition by competitively binding miR-141-3p.
    Qian W; Cai X; Qian Q; Peng W; Yu J; Zhang X; Tian L; Wang C
    Cell Death Dis; 2019 Feb; 10(2):129. PubMed ID: 30755599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA FBXL19-AS1 induces tumor growth and metastasis by sponging miR-203a-3p in lung adenocarcinoma.
    Wang L; Zhang X; Liu Y; Xu S
    J Cell Physiol; 2020 Apr; 235(4):3612-3625. PubMed ID: 31566718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA TTN-AS1 promotes the progression of cholangiocarcinoma via the miR-320a/neuropilin-1 axis.
    Zhu H; Zhai B; He C; Li Z; Gao H; Niu Z; Jiang X; Lu J; Sun X
    Cell Death Dis; 2020 Aug; 11(8):637. PubMed ID: 32801339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGFβ mediated LINC00273 upregulation sponges mir200a-3p and promotes invasion and metastasis by activating ZEB1.
    Sarkar A; Rahaman A; Biswas I; Mukherjee G; Chatterjee S; Bhattacharjee S; Mandal DP
    J Cell Physiol; 2020 Oct; 235(10):7159-7172. PubMed ID: 32017082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fibrotic microenvironment promotes the metastatic seeding of tumor cells into the lungs via mediating the ZEB1-AS1/miR-200b-3p/ZEB1 signaling.
    Liu J; Cao L; Meng J; Li Y; Deng P; Pan P; Hu C; Yang H
    Cell Cycle; 2020 Oct; 19(20):2701-2719. PubMed ID: 33017562
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Chi C; Mao M; Shen Z; Chen Y; Chen J; Hou W
    Hum Gene Ther; 2018 Dec; 29(12):1438-1448. PubMed ID: 29896986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 20. ACTA2-AS1 suppresses lung adenocarcinoma progression via sequestering miR-378a-3p and miR-4428 to elevate SOX7 expression.
    Ying K; Wang L; Long G; Lian C; Chen Z; Lin W
    Cell Biol Int; 2020 Dec; 44(12):2438-2449. PubMed ID: 32808728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.